FDA Approves First Treatment for MCT8 Deficiency

Reports

3

Domains carrying it

3

First reported

28 September 2026

Latest report

30 September 2026

◆ Sectors

◆ Where

United States

◆ Timeline

1. 28 September 2026FDA Approves First Treatment for MCT8 Deficiencyfda.gov
2. 29 September 2026FDA Approves Tiratricol, First Treatment for MCT8 Deficiencypharmacytimes.com
3. 30 September 2026FDA Approves First Treatment for Rare Thyroid Hormone Disordermedpagetoday.com

◆ Connected developments

Situations Wire finds semantically close to this one. Proximity, not cause.

• FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage ...4 reports · 4 domains · 1 September 2026
• U.S. FDA Accepts Teva's New Drug Application (NDA) and Grants Priority Review for ...2 reports · 2 domains · 20 August 2026
• Bayer's KERENDIA® (finerenone) Receives FDA Approval as the First New Treatment in 30 ...2 reports · 2 domains · 17 September 2026
• FDA Approves Mavacamten for Pediatric Patients With Obstructive HCM3 reports · 3 domains · 2 October 2026
• FDA approves Camzyos for adolescents with symptomatic obstructive hypertrophic cardiomyopathy3 reports · 3 domains · 1 October 2026
• Curium™ announces FDA approval of BEXLUTRY lutetium Lu 177 dotatate injection for ...4 reports · 4 domains · 17 September 2026

◆ Share

◆ Evidence

3 reports · 3 domains

• FDA Approves First Treatment for Rare Thyroid Hormone Disordermedpagetoday.com · 30 September 2026
• FDA Approves Tiratricol, First Treatment for MCT8 Deficiencypharmacytimes.com · 29 September 2026
• FDA Approves First Treatment for MCT8 Deficiencyfda.gov · 28 September 2026